The possibility of using shogaol for treatment of ulcerative colitis

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 119

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-21-9_011

تاریخ نمایه سازی: 27 مهر 1400

چکیده مقاله:

Objective(s): This study aimed to investigate the effect of Shogaol on dextran sodium sulfate (DSS)- induced ulcerative colitis (UC) in mice compared to an immune-suppressant chemotherapeutic medicine, known as ۶-thioguanine (۶-TG). Materials and Methods: Thirty-six adult BALB/c mice were divided into six groups: group ۱ (positive control): no DSS exposure and no treatment; group ۲ (negative control): DSS exposure without treatment; group ۳ (vehicle control): DSS exposure and olive oil treatment; group ۴: DSS exposure and ۰.۳ mg/kg ۶-TG treatment; group ۵: DSS exposure and ۲۰ mg/kg Shogaol treatment; and group ۶: DSS exposure and ۴۰ mg/kg Shogaol treatment. At day ۱۶, the mice were euthanized and UC was evaluated according to colon length, histologically index score and expression scores of the epidermal growth factor receptor (EGFR).Results: The disease activity index (DAI) and histological index scores of mice treated with ۴۰ mg/kg body weight (BW) Shogaol were approximately lower than the corresponding scores of mice treated with ۶-TG. In addition, the rate of healing in the former mice was approximately ۳ folds higher than that of the latter ones as indicated by the lack of EGFR expression in colonic glands and macrophages. Conclusion: These findings showed that the therapeutic effect of ۴۰ mg/kg BW Shogaol could be better than ۶-TG in the treatment of UC, and it may draw the attention regarding the priority of using this cheap plant-derived substance for treatment of the inflammatory bowel diseases because treatment with ۶-TG is usually associated with adverse side effects.

نویسندگان

Snur Hassan

Department of Anatomy and Pathology, College of Veterinary Medicine, Sulaimani University, Kurdistan, Iraq

Ali Hassan

Department of Anatomy and Pathology, College of Veterinary Medicine, Sulaimani University, Kurdistan, Iraq

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Xavier R, Podolsky D. Unravelling the pathogenesis of inflammatory bowel ...
  • Brant SR. Update on the heritability of inflammatory bowel disease: ...
  • Chassaing B, Darfeuille–Michaud A. The commensal microbiota and enteropathogens in ...
  • Riva G, Wiederhold B, Mantovani F, Gaggioli A. Interreality: the ...
  • Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, ...
  • Toiyama Y, Mizoguchi A, Okugawa Y, Koike Y, Morimoto Y, ...
  • Farombi EO, Adedara IA, Ajayi BO, Ayepola OR, Egbeme EE. ...
  • Bernstein CN. Treatment of IBD: where we are and where ...
  • Neurath MF. Current and emerging therapeutic targets for IBD. Nat ...
  • Ok S, Jeong WS. Optimization of extraction conditions for the ...
  • Hu R, Zhou P, Peng YB, Xu X, Ma J, ...
  • Cohen S, Carpenter G. Human epidermal growth factor: isolation and ...
  • Wright NA, Pike C, Elia G. Induction of a novel ...
  • Yarden Y. The EGFR family and its ligands in human ...
  • Kitajima S, Takuma S, Morimoto M. Histological analysis of murine ...
  • Kverka M, Rossmann P, Tlaskalova-Hogenova H, Klimesova K, Jharap B, ...
  • Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, ...
  • Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, ...
  • Bourouba M, Benyelles-Boufennara A, Terki N, Baraka-Kerboua E, Bouzid K, ...
  • Gu Y, Zhang S, Wu Q, Xu S, Cui Y, ...
  • Qualls JE, Tuna H, Kaplan AM, Cohen DA. Suppression of ...
  • Cominelli F, Arseneau KO, Rodriguez-Palacios A, Pizarro TT. Uncovering Pathogenic ...
  • Abu-Gharbieh E, Bayoumi FA, Ahmed NG. Alleviation of antioxidant defense ...
  • Levy AS, Simon O, Shelly J, Gardener M. ۶-Shogaol reduced ...
  • Zhang M, Xu C, Liu D, Han MK, Wang L, ...
  • Dubé PE, Yan F, Punit S, Girish N, McElroy SJ, ...
  • Lu N, Wang L, Cao H, Liu L, Van Kaer ...
  • Gill RA, Onstad GR, Cardamone JM, Maneval DC, Sumner HW. ...
  • Weiss RB, Poster DS. The renal toxicity of cancer chemotherapeutic ...
  • نمایش کامل مراجع